Dr. Toma Aesthetics
Book
Botox & neurotoxins · Hugel

Letybo in Naples, FL

Letybo (letibotulinumtoxinA-wlbg) was approved by the FDA on February 29, 2024 for glabellar (frown) lines. Dr. Toma offers it as an alternative to other brands, with its own label dose of 20 units across 5 sites.

Book LetyboFull Botox & neurotoxins guide
Reviewed by Dr. Irina Toma, DDS, last reviewed Oct 25, 2026
Onset
3 to 5 days
Full effect
2 weeks
Typically lasts
3 to 4 months
varies
Units
20 glabella
label dose

What Letybo is approved for

Moderate to severe glabellar (frown) lines in adults.

On-labelFDA label summary: Temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients. Source: Letybo Prescribing Information, verified Oct 2026.

Treatment outside these areas is off-label, legal and common; it is discussed and consented to at your consultation.

When Dr. Toma reaches for Letybo

  • Approved in the US in 2024 for glabellar lines.
  • Dosed on a unit scale similar to Botox, so plans translate easily.
  • A useful alternative for patients who feel a previous brand has become less effective.

Letybo compared with Botox

LetyboBotox
US approvalFeb 29, 20242002 (cosmetic)
Label areasGlabellar linesGlabella, crow's feet, forehead, platysma
Onset3 to 5 days3 to 5 days
Duration3 to 4 months3 to 4 months

Label wording verified Oct 2026. Units are not interchangeable between neurotoxin brands.

Cost of Letybo in Naples

Pricing is shared in writing at your consultation and lists the product, amount per area and total before anything is placed. Prices carry their effective dates.

Questions about Letybo

A botulinum toxin type A from Hugel, approved by the FDA on February 29, 2024 for glabellar (frown) lines only.

Similar onset, duration and unit scale in trials. The main difference is the label, which covers frown lines only; other areas are off-label.

It carries the same boxed warning as every neurotoxin about distant spread, and the same contraindications. Full consent is reviewed before treatment.

Medically reviewed by Dr. Irina Toma, DDS
Dentist, FL Lic. DN25459, last reviewed Oct 25, 2026

References: Letybo Prescribing Information, BLA 761225 (Hugel), 2024. Letybo is a registered trademark of Hugel. Individual results vary. This page is educational and not a substitute for a consultation.

Dr. Irina Toma with neurotoxin vials
Book your private consultation

Book your Letybo consultation

Brand, dose and area are chosen with you, for your anatomy and history, and written down before anything is placed.

By appointment only, 3411 Tamiami Trail N #200, Naples, FL 34103, info@dririnatoma.com

Or contact me for
We reply by text. No marketing messages.